Centessa Looks To Transform Drug Development With ‘Asset Centric’ Model
Company Bags $250m In Series A
In an interview with Scrip, CEO Saurabh Saha elaborates on the first-of-its-kind R&D model.
You may also be interested in...
Plus deals involving Sanofi/SIRION, Merck KGAA/Day One, Beijing Tide/Graviton, Vaccinex/Surface Oncology, Athena/Tris, Biomunex/Onward, Cellectis/Cytovia
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Novadiscovery has received funding from Sanofi and will support the French major’s COVID-19 efforts with its virtual JINKO clinical trial platform.